SEC Form 4 · accession 0001019687-16-005323
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sharon Surrey Barbari
Director
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 7:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per shareF1 | Feb 29, 2016 | A | 4,356 | — | A | 4,356 | D | |
| Common Stock, $0.0001 par value per shareF2 | Feb 29, 2016 | A | 11,250 | — | A | 15,606 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The stock was granted by the Issuer as a quarterly retainer pursuant to the Non-Employee Director Compensation Plan.
- F2The stock was granted as an annual grant by the Issuer pursuant to the Non-Employee Director Compensation Plan.